These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9630370)

  • 41. Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease.
    Bongaerts GP; Lyerly DM
    Microb Pathog; 1997 Apr; 22(4):253-6. PubMed ID: 9140922
    [No Abstract]   [Full Text] [Related]  

  • 42. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
    Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
    Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virulence factors of Clostridium difficile.
    Borriello SP; Davies HA; Kamiya S; Reed PJ; Seddon S
    Rev Infect Dis; 1990; 12 Suppl 2():S185-91. PubMed ID: 2406871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dramatic increase of Clostridium difficile-associated diarrhea in Germany: has the new strain PCR-ribotype 027 already reached us?].
    Reichardt C; Chaberny IF; Kola A; Mattner F; Vonberg RP; Gastmeier P
    Dtsch Med Wochenschr; 2007 Feb; 132(5):223-8. PubMed ID: 17252365
    [No Abstract]   [Full Text] [Related]  

  • 45. Virulence factors of Clostridium difficile and their role during infection.
    Janoir C
    Anaerobe; 2016 Feb; 37():13-24. PubMed ID: 26596863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile.
    Toyokawa M; Ueda A; Tsukamoto H; Nishi I; Horikawa M; Sunada A; Asari S
    J Infect Chemother; 2003 Dec; 9(4):351-4. PubMed ID: 14691659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.
    Mahe S; Corthier G; Dubos F
    Infect Immun; 1987 Aug; 55(8):1801-5. PubMed ID: 3610315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxin A-negative, toxin B-positive Clostridium difficile.
    Drudy D; Fanning S; Kyne L
    Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The American Cockroach Peptide Periplanetasin-2 Blocks
    Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
    J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of flagella in Clostridium difficile pathogenicity.
    Stevenson E; Minton NP; Kuehne SA
    Trends Microbiol; 2015 May; 23(5):275-82. PubMed ID: 25659185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colonization by Clostridium difficile in hospitalized children: risk factors and typification of the isolated strains.
    Camorlinga M; Muñoz O; Guiscafré H; Torres J
    Arch Invest Med (Mex); 1991; 22(1):19-26. PubMed ID: 1819972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenesis and diagnosis of clostridium difficile enterocolitis.
    Möllby R; Aronsson B; Nord CE
    Scand J Infect Dis Suppl; 1985; 46():47-56. PubMed ID: 3906856
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of virulence genes of Clostridium difficile by multiplex PCR.
    Antikainen J; Pasanen T; Mero S; Tarkka E; Kirveskari J; Kotila S; Mentula S; Könönen E; Virolainen-Julkunen AR; Vaara M; Tissari P
    APMIS; 2009 Aug; 117(8):607-13. PubMed ID: 19664132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemic strains of Clostridium difficile are present in Auckland, New Zealand.
    Roberts S; Heffernan H; Al Anbuky N; Richardson A; Swager T; Taylor SL; Bower J; Williamson D; Freeman JT
    N Z Med J; 2011 Apr; 124(1332):97-101. PubMed ID: 21747433
    [No Abstract]   [Full Text] [Related]  

  • 55. Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.
    Pollock NR
    J Clin Microbiol; 2016 Feb; 54(2):259-64. PubMed ID: 26659205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of capsule in strains of Clostridium difficile of varying virulence and toxigenicity.
    Davies HA; Borriello SP
    Microb Pathog; 1990 Aug; 9(2):141-6. PubMed ID: 2277588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical-site infection with toxin A-nonproducing and toxin B-producing Clostridium difficile.
    Kikkawa H; Miyamoto K; Takiguchi N; Kondo T; Hitomi S
    J Infect Chemother; 2008 Feb; 14(1):59-61. PubMed ID: 18297452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The role of Clostridium difficile in human pathology].
    Malov VA; Bondarenko VM; Pak SG
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):91-6. PubMed ID: 8820690
    [No Abstract]   [Full Text] [Related]  

  • 59. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
    Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clostridium difficile infection: molecular pathogenesis and novel therapeutics.
    Rineh A; Kelso MJ; Vatansever F; Tegos GP; Hamblin MR
    Expert Rev Anti Infect Ther; 2014 Jan; 12(1):131-50. PubMed ID: 24410618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.